These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 3115002)

  • 1. Specific and nonspecific protection of mice by Pseudomonas aeruginosa lipopolysaccharides.
    Marx A; Meitert E; Salageanu A; Olinescu A; Savulian C; Sima F; Chersulick E
    Zentralbl Bakteriol Mikrobiol Hyg A; 1987 Apr; 264(1-2):154-62. PubMed ID: 3115002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serotype-nonspecific protection induced by ribonucleic acid isolated from the ribosomal vaccine of Pseudomonas aeruginosa.
    Gonggrijp R; Mullers WJ; van Boven CP
    Infect Immun; 1981 Jul; 33(1):178-85. PubMed ID: 6167518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prophylactic and therapeutic efficacy of immunoglobulin G antibodies to Pseudomonas aeruginosa lipopolysaccharide against murine experimental corneal infection.
    Preston MJ; Gerçeker AA; Koles NL; Pollack M; Pier GB
    Invest Ophthalmol Vis Sci; 1997 Jun; 38(7):1418-25. PubMed ID: 9191605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific and non-specific mouse protection induced by different chemotypes of the Pseudomonas aeruginosa lipopolysaccharides.
    Stanislavsky ES; Makarenko TA; Kozhenova TE
    FEMS Microbiol Immunol; 1992 Oct; 5(4):181-9. PubMed ID: 1419116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective activities of ribosomal ribonucleic acid and lipopolysaccharide of Pseudomonas aeruginosa: a comparative study.
    Gonggrijp R; Mullers WJ; van Boven CP
    Antonie Van Leeuwenhoek; 1983 Jun; 49(2):173-82. PubMed ID: 6193755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-17 is a critical component of vaccine-induced protection against lung infection by lipopolysaccharide-heterologous strains of Pseudomonas aeruginosa.
    Priebe GP; Walsh RL; Cederroth TA; Kamei A; Coutinho-Sledge YS; Goldberg JB; Pier GB
    J Immunol; 2008 Oct; 181(7):4965-75. PubMed ID: 18802100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pseudomonas aeruginosa antigens as potential vaccines.
    Stanislavsky ES; Lam JS
    FEMS Microbiol Rev; 1997 Nov; 21(3):243-77. PubMed ID: 9451816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of lipopolysaccharide-induced protection against pseudomonas sepsis in granulocytopenic mice.
    Tegtmeier BR; Andersen BR
    Rev Infect Dis; 1983; 5 Suppl 5():S963-70. PubMed ID: 6419318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection against infection with Pseudomonas aeruginosa by passive transfer of monoclonal antibodies to lipopolysaccharides and outer membrane proteins.
    Sawada S; Suzuki M; Kawamura T; Fujinaga S; Masuho Y; Tomibe K
    J Infect Dis; 1984 Oct; 150(4):570-6. PubMed ID: 6436393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective immunity induced in mice by immunization with high-molecular-weight polysaccharide from Pseudomonas aeruginosa.
    Pier GB; Sidberry HF; Sadoff JC
    Infect Immun; 1978 Dec; 22(3):919-25. PubMed ID: 103841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection against fatal Pseudomonas aeruginosa sepsis by immunization with smooth and rough lipopolysaccharides.
    Cryz SJ; Meadow PM; Fürer E; Germanier R
    Eur J Clin Microbiol; 1985 Apr; 4(2):180-5. PubMed ID: 3924605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacodynamic and protective properties of a murine lipopolysaccharide-specific monoclonal antibody in experimental Pseudomonas aeruginosa pneumonia in mice.
    Oishi K; Sonoda F; Miwa H; Tanaka H; Watanabe K; Matsumoto K; Pollack M
    Microbiol Immunol; 1991; 35(12):1131-41. PubMed ID: 1808464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of high-affinity anti-Pseudomonas aeruginosa lipopolysaccharide antibodies induced by immunization on the rate of Pseudomonas aeruginosa infection in patients with cystic fibrosis.
    Lang AB; Schaad UB; Rüdeberg A; Wedgwood J; Que JU; Fürer E; Cryz SJ
    J Pediatr; 1995 Nov; 127(5):711-7. PubMed ID: 7472821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Properties determining the potential of naturally occurring and vaccine-induced human antibodies to protect against lethal infection of Pseudomonas aeruginosa.
    Bruderer U; Fürer E; Cryz SJ; Lang AB
    Res Immunol; 1992 Feb; 143(2):165-74. PubMed ID: 1374194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Affinity constants of naturally acquired and vaccine-induced anti-Pseudomonas aeruginosa antibodies in healthy adults and cystic fibrosis patients.
    Bruderer U; Cryz SJ; Schaad UB; Deusinger M; Que JU; Lang AB
    J Infect Dis; 1992 Aug; 166(2):344-9. PubMed ID: 1634805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-protection by Pseudomonas aeruginosa polysaccharides.
    Pier GB
    Infect Immun; 1982 Dec; 38(3):1117-22. PubMed ID: 6185423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Construction of a Protective Vaccine Against Lipopolysaccharide-Heterologous
    Liu C; Pan X; Xia B; Chen F; Jin Y; Bai F; Priebe G; Cheng Z; Jin S; Wu W
    Front Immunol; 2018; 9():1737. PubMed ID: 30093906
    [No Abstract]   [Full Text] [Related]  

  • 18. Active immunization with lipopolysaccharide Pseudomonas antigen for chronic Pseudomonas bronchopneumonia in guinea pigs.
    Pennington JE; Hickey WF; Blackwood LL; Arnaut MA
    J Clin Invest; 1981 Nov; 68(5):1140-8. PubMed ID: 6795229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A polyreactive human anti-lipid A monoclonal antibody having cross reactivity to polysaccharide portions of Pseudomonas aeruginosa lipopolysaccharides.
    Yokota S; Ohtsuka H; Kohzuki T; Noguchi H
    FEMS Immunol Med Microbiol; 1996 May; 14(1):31-8. PubMed ID: 8804973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outer membrane protein F (porin) preparation of Pseudomonas aeruginosa as a protective vaccine against heterologous immunotype strains in a burned mouse model.
    Matthews-Greer JM; Gilleland HE
    J Infect Dis; 1987 Jun; 155(6):1282-91. PubMed ID: 3033095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.